Es gab 50 kürzliche Insider-Transaktionen für Salarius Pharmaceuticals, Inc. (SLRX), darunter 50 Käufe und 0 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $810.78K und die gesamten Insider-Verkäufe auf RSU Award.
Bedeutende Insider mit kürzlicher Aktivität umfassen Arthur David J., Hanish Arnold C, Rosenblum Mark J. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — SLRX
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2024-04-11 |
Arthur David J. |
Chief Executive Officer |
RSU-Zuteilung |
20,500 |
$0.51 |
$10.46K |
20,500 |
| 2024-02-20 |
Hanish Arnold C |
Director |
RSU-Zuteilung |
20,500 |
$0.57 |
$11.71K |
20,500 |
| 2024-02-20 |
Rosenblum Mark J |
Exec VP Finance, CFO |
RSU-Zuteilung |
22,500 |
$0.57 |
$12.85K |
22,500 |
| 2024-02-20 |
Lieber Jonathan I |
Director |
RSU-Zuteilung |
20,500 |
$0.57 |
$11.71K |
20,500 |
| 2024-02-20 |
Lammers Paul |
Director |
RSU-Zuteilung |
20,500 |
$0.57 |
$11.71K |
20,500 |
| 2024-02-20 |
Mcvicar William K. |
Director |
RSU-Zuteilung |
20,500 |
$0.57 |
$11.71K |
20,500 |
| 2024-02-20 |
Burleson Tess |
Director |
RSU-Zuteilung |
20,500 |
$0.57 |
$11.71K |
20,500 |
| 2024-02-20 |
Mccreedy Bruce J Jr. |
Director |
RSU-Zuteilung |
20,500 |
$0.57 |
$11.71K |
20,500 |
| 2023-02-13 |
Rosenblum Mark J |
Exec VP Finance, CFO |
RSU-Zuteilung |
6,432 |
- |
- |
21,851 |
| 2023-02-13 |
Arthur David J. |
Chief Executive Officer |
RSU-Zuteilung |
14,300 |
- |
- |
48,019 |
| 2023-01-03 |
Hanish Arnold C |
Director |
RSU-Zuteilung |
1,440 |
- |
- |
1,440 |
| 2023-01-03 |
Rosenblum Mark J |
Exec VP Finance, CFO |
RSU-Zuteilung |
8,000 |
- |
- |
15,419 |
| 2023-01-03 |
Lieber Jonathan I |
Director |
RSU-Zuteilung |
1,440 |
- |
- |
2,940 |
| 2023-01-03 |
Lammers Paul |
Director |
RSU-Zuteilung |
1,440 |
- |
- |
1,718 |
| 2023-01-03 |
Mcvicar William K. |
Director |
RSU-Zuteilung |
1,440 |
- |
- |
1,788 |
| 2023-01-03 |
Arthur David J. |
Chief Executive Officer |
RSU-Zuteilung |
20,000 |
- |
- |
33,719 |
| 2023-01-03 |
Burleson Tess |
Director |
RSU-Zuteilung |
1,440 |
- |
- |
2,722 |
| 2023-01-03 |
Mccreedy Bruce J Jr. |
Director |
RSU-Zuteilung |
1,440 |
- |
- |
1,788 |
| 2022-11-03 |
Rosenblum Mark J |
Exec VP Finance, CFO |
RSU-Zuteilung |
7,314 |
$1.73 |
$12.68K |
155,633 |
| 2022-11-03 |
Arthur David J. |
Chief Executive Officer |
RSU-Zuteilung |
10,000 |
$1.73 |
$17.34K |
285,674 |
| 2022-11-03 |
Rosenblum Mark J |
Exec VP Finance, CFO |
RSU-Zuteilung |
7,314 |
$1.73 |
$12.68K |
13,245 |
| 2022-11-03 |
Arthur David J. |
Chief Executive Officer |
RSU-Zuteilung |
10,000 |
$1.73 |
$17.34K |
21,026 |
| 2022-11-03 |
Rosenblum Mark J |
Exec VP Finance, CFO |
RSU-Zuteilung |
1,488 |
$1.73 |
$2.58K |
7,419 |
| 2022-11-03 |
Arthur David J. |
Chief Executive Officer |
RSU-Zuteilung |
2,693 |
$1.73 |
$4.67K |
13,719 |
| 2022-06-07 |
Lieber Jonathan I |
Director |
Informierter Kauf |
37,500 |
$0.19 |
$7.02K |
37,500 |
| 2022-06-07 |
Burleson Tess |
Director |
Informierter Kauf |
27,700 |
$0.18 |
$4.99K |
32,050 |
| 2022-06-06 |
Mcvicar William K. |
Director |
Informierter Kauf |
26,553 |
$0.19 |
$5K |
26,553 |
| 2022-06-03 |
Hanish Arnold C |
Director |
Informierter Kauf |
28,000 |
$0.18 |
$5.15K |
46,350 |
| 2022-05-31 |
Rosenblum Mark J |
Exec VP Finance, CFO |
Informierter Kauf |
28,000 |
$0.18 |
$5.04K |
148,319 |
| 2022-05-26 |
Arthur David J. |
Chief Executive Officer |
Informierter Kauf |
3,400 |
$0.18 |
$612.00 |
263,074 |
| 2022-05-03 |
Rosenblum Mark J |
Exec VP Finance, CFO |
RSU-Zuteilung |
10,000 |
$0.19 |
$1.86K |
120,319 |
| 2022-05-03 |
Arthur David J. |
Chief Executive Officer |
RSU-Zuteilung |
10,000 |
$0.19 |
$1.86K |
259,674 |
| 2022-03-03 |
Rosenblum Mark J |
Exec VP Finance, CFO |
Informierter Kauf |
76,246 |
$0.39 |
$29.81K |
110,319 |
| 2022-03-03 |
Arthur David J. |
Chief Executive Officer |
Informierter Kauf |
139,488 |
$0.39 |
$54.54K |
249,674 |
| 2022-01-20 |
Hanish Arnold C |
Director |
RSU-Zuteilung |
30,000 |
$0.48 |
$14.4K |
30,000 |
| 2022-01-20 |
Rosenblum Mark J |
Exec VP Finance, CFO |
RSU-Zuteilung |
200,000 |
$0.48 |
$96K |
200,000 |
| 2022-01-20 |
Lieber Jonathan I |
Director |
RSU-Zuteilung |
30,000 |
$0.48 |
$14.4K |
30,000 |
| 2022-01-20 |
Lammers Paul |
Director |
RSU-Zuteilung |
30,000 |
$0.48 |
$14.4K |
30,000 |
| 2022-01-20 |
Mcvicar William K. |
Director |
RSU-Zuteilung |
30,000 |
$0.48 |
$14.4K |
30,000 |
| 2022-01-20 |
Arthur David J. |
Chief Executive Officer |
RSU-Zuteilung |
500,000 |
$0.48 |
$240K |
500,000 |
| 2022-01-20 |
Burleson Tess |
Director |
RSU-Zuteilung |
30,000 |
$0.48 |
$14.4K |
30,000 |
| 2022-01-20 |
Mccreedy Bruce J Jr. |
Director |
RSU-Zuteilung |
30,000 |
$0.48 |
$14.4K |
30,000 |
| 2021-11-03 |
Rosenblum Mark J |
Exec VP Finance, CFO |
RSU-Zuteilung |
7,787 |
$0.72 |
$5.59K |
34,073 |
| 2021-11-03 |
Arthur David J. |
Chief Executive Officer |
RSU-Zuteilung |
7,939 |
$0.72 |
$5.7K |
110,186 |
| 2021-08-17 |
Arthur David J. |
Chief Executive Officer |
Informierter Kauf |
2,000 |
$0.90 |
$1.8K |
100,247 |
| 2021-08-10 |
Hanish Arnold C |
Director |
Informierter Kauf |
7,000 |
$0.88 |
$6.17K |
18,350 |
| 2021-05-03 |
Rosenblum Mark J |
Exec VP Finance, CFO |
RSU-Zuteilung |
9,563 |
$0.57 |
$5.42K |
26,286 |
| 2021-05-03 |
Arthur David J. |
Chief Executive Officer |
RSU-Zuteilung |
9,822 |
$0.57 |
$5.57K |
96,247 |
| 2020-12-02 |
Hanish Arnold C |
Director |
RSU-Zuteilung |
30,000 |
$0.74 |
$22.2K |
30,000 |
| 2020-12-02 |
Rosenblum Mark J |
Exec VP Finance, CFO |
RSU-Zuteilung |
80,000 |
$0.74 |
$59.2K |
80,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
